Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised / Juuli 2022

Arhiiv

✕

9 juuli 2022

2181

Broadway Bares raise $1.8 million to fight HIV

Broadway Bares raise $1.8 million to fight HIV

In honour of the 30th anniversary of the fight against HIV, in just one night, more than 170 talented actors, dancers and circus performers were able to fundraise a total of $1,890,000 for Broadway Cares/Equity Fights AIDS (BCEFA). This year’s show was a return to in-person ...

9 juuli 2022

1980

Scientists have determined which immune cells HIV “prefers”

Scientists have determined which immune cells HIV “prefers”

Scientists have discovered new aspects of the HIV infection process and determined what factors the virus uses to choose which immune cells to infect. It turns out it's all about sugar. The results of the relevant study are published in eLife. We know that HIV prefers ...

9 juuli 2022

1924

Scientists find another “weak point” in HIV

Scientists find another “weak point” in HIV

A group of scientists, based in the United States, have determined the molecular structure of the HIV protein which plays a key role in the late stages of viral replication. Understanding how HIV replicates inside cells is the key to developing new treatments and prevention ...

9 juuli 2022

1699

Timely treatment of Hepatitis C improves cognitive function

Timely treatment of Hepatitis C improves cognitive function

According to the results of a study people who have successfully been treated for hepatitis C with direct-acting antiviral (DAA) therapy showed an improvement in both mood and cognitive functions. Chronic infection of Hepatitis C virus (HCV) can lead to severe liver diseases, ...

9 juuli 2022

2012

HIV drug, Lamivudine, may improve cognitive function for those with Down’s Syndrome

HIV drug, Lamivudine, may improve cognitive function for those with Down’s Syndrome

According to a study by scientists from the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research Institute, the drug lamivudine, which is used to treat HIV, could improve cognitive functions in those living with Down’s syndrome. Tests so far have been conducted ...

9 juuli 2022

1759

People living with HIV at higher risk of peripheral artery disease

People living with HIV at higher risk of peripheral artery disease

Scientists from Denmark have published a study in the journal AIDS, in which they claim that people living with HIV are at increased risk of peripheral artery disease. Peripheral artery disease can lead to problems with the heart, blood vessels and blood circulation. ...

9 juuli 2022

1796

Dolutegravir-based therapy leads to fewer failures in adolescents says study

Dolutegravir-based therapy leads to fewer failures in adolescents says study

Phase-III results of the multi-country ODYSSEY study have shown that dolutegravir (DTG) based therapy, used in Line 1 and Line 2 regimens, leads to fewer treatment failures than other drug combinations. The results were published in IDSE magazine. The results of the ...

9 juuli 2022

2181

B-cell HIV therapy: a new study

B-cell HIV therapy: a new study

Researchers from Tel Aviv claim that their new B-cell therapy can cure HIV with just a single injection. The drug appeared to be effective during early animal testing. The new B-cell treatment makes use of the CRISPR system (think of it like cut, copy and paste on your ...

9 juuli 2022

1892

We’re “people living with HIV” not just “HIV-Positive”. It’s all in the wording.

We’re “people living with HIV” not just “HIV-Positive”. It’s all in the wording.

The wording used by the media, doctors and scientists in connection with HIV has a strong impact on the stigmatisation of people living with HIV. Language focused on humans, not disease, can be one way to solve this problem, writes aidsmap, referring to a study by Dr. Kristen ...

9 juuli 2022

2032

Gilead: The quality of life of people with an undetectable viral load is the same as that of the general population

Gilead: The quality of life of people with an undetectable viral load is the same as that of the general population

One-hundred-and-twenty people who were living with HIV and virally suppressed were surveyed, using the EQ-5D-5L questionnaire, which assesses quality of life in across with five areas: mobility, self-care, daily activities, pain/discomfort and anxiety/depression. For ...

1 2